top of page
Search Results
Results found for "Kallyope"
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
May 2022 Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal sophisticated technologies that drive creation of new drug discovery programs in key therapeutic areas Kallyope 2022 – Sosei Group Corporation, the international biopharmaceutical company, and New York City-based Kallyope
- 📰 GPCR Weekly News, November 6 to November 12, 2023
Modulators in Neurological Disorders at Jefferies Healthcare Conference in London Sosei Heptares and Kallyope
bottom of page